Irwin, Kelly, MD, MPH

Founding Director
Collaborative Care and Community Engagement Program
Massachusetts General Hospital Cancer Center

Instructor in Psychiatry
Harvard Medical School


Dr. Kelly Irwin is a psychiatrist and health services researcher at the Massachusetts General Hospital (MGH) Cancer Center and MGH Schizophrenia Program who studies health care disparities in patients with serious mental illness (SMI) and cancer. Dr. Irwin received her MD from Harvard Medical School in 2008 and completed her residency in psychiatry at MGH and McLean in 2012. She is the founding director of the Collaborative Care and Community Engagement Program at the MGH Cancer Center, a clinical and research initiative dedicated to achieving equity in cancer care for people with SMI. Dr. Irwin is interested in understanding why individuals with SMI including schizophrenia and bipolar disorder are twice as likely to die from cancer and in developing interventions to improve their cancer outcomes. She is a principal investigator in the Cancer Outcomes Research Program and the MGH Schizophrenia Program. Dr. Irwin’s team is conducting a series of studies focused on improving cancer outcomes throughout the continuum of cancer care for people with SMI. With funding from the American Cancer Society, she developed and piloted an innovative model of proactive psychiatry consultation for individuals with serious mental illness and cancer which was highlighted in an editorial in the New England Journal of Medicine. Dr. Irwin is currently conducting a randomized controlled trial (BRIDGE) to assess the impact of this intervention on cancer care. Over the past year, Dr. Irwin was awarded funding from the Massachusetts Department of Mental Health, the MGH Cancer Center, and MGH Psychiatry, to sustain and grow her research program. Dr. Irwin was recently awarded a Patient-Centered Outcomes Research Institute (PCORI) Engagement Award to launch a Cancer and Mental Health Collaborative to build a community network of diverse stakeholders to advance patient-centered research focused on cancer and SMI and create sustainable channels to disseminate research findings.


Privacy Statement

This website uses Echo360 technologies. Echo360 partners with the world’s leading educational institutions and industry associations to enhance the teaching and learning experience for students and professionals like you. Our goal is to enable a more engaging and successful learning experience by providing you with live and on-demand access to study tools, videos, and collaboration capabilities in an online classroom to help you achieve your educational goals. We believe you should always know what data we collect from you and how we use it. As part of our ongoing commitment to transparency, and to support new European data protection laws, we're updating our Privacy Policy to inform you about the information that you share with us.

The revised policy will take effect on May 25, 2018. By using our services on or after that date, you'll be agreeing to these updates. We encourage you to read this document in full.

Echo360, Inc. 11955 Freedom Drive, Suite 700, Reston, VA 20190 USA